This is not the most recent version of the article. View current version (6 MAR 2014)

Intervention Review

You have free access to this content

Vaccines for preventing influenza in people with cystic fibrosis

  1. Poonam Dharmaraj1,*,
  2. Rosalind L Smyth2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 27 JUN 2011

DOI: 10.1002/14651858.CD001753.pub2


How to Cite

Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001753. DOI: 10.1002/14651858.CD001753.pub2.

Author Information

  1. 1

    Alder Hey Children's NHS Foundation Trust, Diabetes & Endocrinology, Liverpool, UK

  2. 2

    Alder Hey Children's NHS Foundation Trust, Institute of Child Health, University of Liverpool, Liverpool, Merseyside, UK

*Poonam Dharmaraj, Diabetes & Endocrinology, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, L12 2AP, UK. poonamd@doctors.org.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article. View current version (06 MAR 2014)

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Adlard 1987 {published data only}
Gruber 1994 {published data only}
  • Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: Results of a 3 year study. Journal of Infectious Diseases 1994;169(2):241-7.
King 1987 {published data only}
Schaad 2000 {published data only}
  • Schaad UB, Bühlmann U, Burger R, Ruedeberg A, Wilder-Smith A, Rutishauser M, et al. Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 2000;44(5):1163-7.
  • Schadd UB, Buehlmann U, Burger R, Wilder-Smtih A, Rutishauser M, Sennhauser FH, et al. Comparison of immunogenicity and safety of a virosome and a subunit influenza vaccine in pediatric cystic fibrosis (CF) patients: A Swiss multicenter study [abstract]. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sept 28 - Oct 01. 1997:238.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Doudounakis 2000 {unpublished data only}
  • Doudounakis S, Velenzas P, Sophianos D, Kikis G, Theodoridou M, Adam G. Comparison of two vaccination schemes against influenza in children with cystic fibrosis [abstract]. Proceedings of the XIIth International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm. 2000:169.
  • Doudounakis S, Velenzas P, Sophianos D, Kikis G, Theodoridou M, Adam G. Efficacy of two different vaccination schemes for influenza annual vaccination in cystic fibrosis patients 3 - 8 years old [abstract]. European Respiratory Journal 2001;18(33):539s.
Ong 1991 {published data only}
  • Ong ELC, Bilton D, Abbott J, Webb AK, McCartney RA, Caul EO. Influenza vaccination in adults with cystic fibrosis. BMJ 1991;303(6802):557.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Ashley 1991
  • Ashley J, Smith T, Dunnel K. Deaths in Great Britain with the influenza epidemic of 1989/1990. Population Trends 1991;62:16-20.
Bernstein 1982
  • Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. American Journal of Diseases of Children 1982;136(6):513-7.
CDC 1999
  • Centers for Disease Control. Prevention and control of influenza: recommendation of the advisory committee on immunisation practices. Morbidity and Mortality Weekly Report 1999;48(RR - 4):1-49.
Collinson 1996
Conway 1992
Ferson 1991
Higgins 2003
HMSO 1996
  • Department of Health, Welsh Office, Scottish Office, DHSS (Northern Ireland). Influenza. In: Salisbury DM, Begg NT editor(s). Immunisation against infectious disease (Green Book). London: HMSO, 1996:113-20.
Holm 1999
Jadad 1996
  • Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
Johansen 1992
McElhaney 1993
Petersen 1981
Ramsey 1989
  • Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. American Journal of Diseases of Children 1989;143(6):662-8.
RevMan 2008
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
RLCH Pharmacy 2009
  • Royal Liverpool Children's Hospital Pharmacy. Personal communication 22 July 2009.
Ryan 1997
  • Ryan F, Shortt C, Bredin C, Watson JB, O'Halloran T. The use of influenza vaccine in patients with cystic fibrosis. Irish Medical Journal 1997;90(8):293.
Smyth 1995
  • Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Archives of Disease in Childhood 1995;73(2):117-20.
Wang 1984
  • Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. New England Journal of Medicine 1984;311(26):1653-8.